Summarized by Masters of Longevity from Longevity Technology.
A biotech prize winner is profiled for its investigational multi-factor stem-cell biologic targeting muscle and metabolic aging; read on for a clear preview of the article’s scope and relevance.
Key Takeaways
- IMM01-STEM is a stem-cell-derived biologic aimed at muscle and metabolic aging.
- Phase 2 randomized trial results report improvements in muscle, metabolism, and quality of life.
- Reported trial data show no severe adverse events attributed to the therapy.
